Global

COVID-19 EPITOPE SCREENING

SARS-CoV-2, the virus that leads to coronavirus disease 19 (COVID-19), has spread rapidly from the first known cases in China in December 2019 to countries around the world.

InnoScan and Coronavirus

On March 2020, the World Health Organization (WHO) reported that there were 113,702 confirmed cases of COVID-19 around the world.

In response to this global health crisis, researchers are working on developing a coronavirus vaccine as soon as possible. InnoScan scanners help virology research and anti-coronavirus vaccine development through their use in COVID-19 epitope screening protocols.
High resolution scanners are being used to scan HD peptide arrays and glycan arrays to identify, profile, and compare specific IgG and IgM antibody responses in patient or animal sera for vaccine development, or screen viral antigens to find and characterize immunodominant epitopes for in-vitro diagnostics research.
InnoScan 910 and InnoScan 1100 scan high density peptide arrays, such as PEPperCHIPĀ®, containing thousand to million peptide sequences on a single slide.